BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

859 related articles for article (PubMed ID: 19280190)

  • 21. Suberoylanilide hydroxamic acid enhances gap junctional intercellular communication via acetylation of histone containing connexin 43 gene locus.
    Ogawa T; Hayashi T; Tokunou M; Nakachi K; Trosko JE; Chang CC; Yorioka N
    Cancer Res; 2005 Nov; 65(21):9771-8. PubMed ID: 16266998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diclofenac, a non-steroidal anti-inflammatory drug, suppresses apoptosis induced by endoplasmic reticulum stresses by inhibiting caspase signaling.
    Yamazaki T; Muramoto M; Oe T; Morikawa N; Okitsu O; Nagashima T; Nishimura S; Katayama Y; Kita Y
    Neuropharmacology; 2006 Apr; 50(5):558-67. PubMed ID: 16388830
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apoptosis-inducing activity of cisplatin (CDDP) against human hepatoma and oral squamous cell carcinoma cell lines.
    Okamura M; Hashimoto K; Shimada J; Sakagami H
    Anticancer Res; 2004; 24(2B):655-61. PubMed ID: 15161008
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The histone deacetylase inhibitor suberoylanilide hydroxamic acid down-regulates expression levels of Bcr-abl, c-Myc and HDAC3 in chronic myeloid leukemia cell lines.
    Xu Y; Voelter-Mahlknecht S; Mahlknecht U
    Int J Mol Med; 2005 Jan; 15(1):169-72. PubMed ID: 15583844
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined effects of sulindac and suberoylanilide hydroxamic acid on apoptosis induction in human lung cancer cells.
    Seo SK; Jin HO; Lee HC; Woo SH; Kim ES; Yoo DH; Lee SJ; An S; Rhee CH; Hong SI; Choe TB; Park IC
    Mol Pharmacol; 2008 Mar; 73(3):1005-12. PubMed ID: 18156316
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of tamoxifen in combination with cisplatin on oral squamous cell carcinoma cell lines.
    Kim MJ; Lee JH; Kim YK; Myoung H; Yun PY
    Cancer Lett; 2007 Jan; 245(1-2):284-92. PubMed ID: 16513256
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative analysis of cell death induction by cisplatin and 5-FU in human oral squamous and hepatocellular carcinoma cell lines.
    Okamura M; Shimada J; Sakagami H
    Anticancer Res; 2008; 28(1A):253-9. PubMed ID: 18383853
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histone deacetylase inhibitors induce cell death and enhance the susceptibility to ionizing radiation, etoposide, and TRAIL in medulloblastoma cells.
    Sonnemann J; Kumar KS; Heesch S; Müller C; Hartwig C; Maass M; Bader P; Beck JF
    Int J Oncol; 2006 Mar; 28(3):755-66. PubMed ID: 16465382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Akt is the downstream target of GRP78 in mediating cisplatin resistance in ER stress-tolerant human lung cancer cells.
    Lin Y; Wang Z; Liu L; Chen L
    Lung Cancer; 2011 Mar; 71(3):291-7. PubMed ID: 20599289
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epigenetic regulation of chemosensitivity to 5-fluorouracil and cisplatin by zebularine in oral squamous cell carcinoma.
    Suzuki M; Shinohara F; Nishimura K; Echigo S; Rikiishi H
    Int J Oncol; 2007 Dec; 31(6):1449-56. PubMed ID: 17982671
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of endoplasmic reticulum stress-induced apoptosis of melanoma cells by the ARC protein.
    Chen LH; Jiang CC; Watts R; Thorne RF; Kiejda KA; Zhang XD; Hersey P
    Cancer Res; 2008 Feb; 68(3):834-42. PubMed ID: 18245485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sequence-specific potentiation of topoisomerase II inhibitors by the histone deacetylase inhibitor suberoylanilide hydroxamic acid.
    Marchion DC; Bicaku E; Daud AI; Richon V; Sullivan DM; Munster PN
    J Cell Biochem; 2004 May; 92(2):223-37. PubMed ID: 15108350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suberoylanilide hydroxamic acid (SAHA) potentiates paclitaxel-induced apoptosis in ovarian cancer cell lines.
    Dietrich CS; Greenberg VL; DeSimone CP; Modesitt SC; van Nagell JR; Craven R; Zimmer SG
    Gynecol Oncol; 2010 Jan; 116(1):126-30. PubMed ID: 19875160
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative evaluation of the treatment efficacy of suberoylanilide hydroxamic acid (SAHA) and paclitaxel in ovarian cancer cell lines and primary ovarian cancer cells from patients.
    Sonnemann J; Gänge J; Pilz S; Stötzer C; Ohlinger R; Belau A; Lorenz G; Beck JF
    BMC Cancer; 2006 Jul; 6():183. PubMed ID: 16834771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histone deacetylase inhibitors reduce VEGF production and induce growth suppression and apoptosis in human mantle cell lymphoma.
    Heider U; Kaiser M; Sterz J; Zavrski I; Jakob C; Fleissner C; Eucker J; Possinger K; Sezer O
    Eur J Haematol; 2006 Jan; 76(1):42-50. PubMed ID: 16343270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heparin induces apoptosis through suppression of AKt in oral squamous cell carcinoma cells.
    Ueda K; Inoue S; Zhang Y; Kutsuna T; Inoue S; Noto K; Arai N; Noguchi M
    Anticancer Res; 2009 Apr; 29(4):1079-88. PubMed ID: 19414349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced susceptibility to tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in oral squamous cell carcinoma cells treated with phosphatidylinositol 3-kinase inhibitors.
    Uchida M; Iwase M; Takaoka S; Yoshiba S; Kondo G; Watanabe H; Ohashi M; Nagumo M; Shintani S
    Int J Oncol; 2007 May; 30(5):1163-71. PubMed ID: 17390018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined histone deacetylase and NF-kappaB inhibition sensitizes non-small cell lung cancer to cell death.
    Rundall BK; Denlinger CE; Jones DR
    Surgery; 2004 Aug; 136(2):416-25. PubMed ID: 15300209
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The histone deacetylase inhibitor suberoylanilide hydroxamic acid sensitises human hepatocellular carcinoma cells to TRAIL-induced apoptosis by TRAIL-DISC activation.
    Carlisi D; Lauricella M; D'Anneo A; Emanuele S; Angileri L; Di Fazio P; Santulli A; Vento R; Tesoriere G
    Eur J Cancer; 2009 Sep; 45(13):2425-38. PubMed ID: 19643600
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bortezomib sensitizes pancreatic cancer cells to endoplasmic reticulum stress-mediated apoptosis.
    Nawrocki ST; Carew JS; Pino MS; Highshaw RA; Dunner K; Huang P; Abbruzzese JL; McConkey DJ
    Cancer Res; 2005 Dec; 65(24):11658-66. PubMed ID: 16357177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.